Our objective is to define the functions of Kell and XK, the two proteins of the Kell blood group system. On red cells Kell and XK are linked by a single disulfide bond. Kell is a 93 kDa type II membrane glycoprotein that preferentially activates endothelin-3. XK is predicted to be a 50.9 kDa protein that has the structural characteristics of a transporter but its function is not known. However, absence of XK, the McLeod phenotype, is associated with red cell acanthocytosis and late onset forms of neuromuscular dysfunctions. To meet our objective we have the following specific aims. (1) To determine the biochemical relationship and cellular locations of Keg and XK in different mouse tissues. In RBCs Kell and XK exist predominantly as a heterodimer. However this may not be the case in nonerythroid tissues where Kell and XK may exist separately. Although Kell is an ectoenzyme its optimal pH for enzyme activity is acidic, raising the possibility that Kell may also have an intracellular location and function. We will therefore determine the cellular locations and possible co-localization of Kell and XK proteins in mouse tissues. (2) To determine the transport functions of XK. Transport functions will be studied in mouse red cells and in transfected Xenopus oocytes. Since on red cells XK is linked to Kell, we postulate that the transport function of XK is modulated by endothelins. We will therefore compare the transport of various solutes in wild-type and Xk-/- red cells and determine if transport is affected by endothelins. We will also express XK, and XK/Kell in Xenopus oocytes and measure membrane conductance by the two-electrode voltage clamp procedure. (3) To determine, utilizing mice with targeted disruption of Kel and Xk, if Kell and XK proteins have complementary functions. The phenotype of double-knockout mice, Kel-/-, Xk-/-, will be compared to that of mice with disruption of only Xk. Emphasis will be placed on differences in the pathology of skeletal muscle and brain, the reproductive system and functions known to be affected by the endothelins. (4). To determine the physiological function of Kell. Is Kell activated in microenvironments that foster low pH? We propose that Kell, as an ectoenzyme with an acidic pH optimum, functions in acidic microenvironments. Acidic microenvironments are known to occur in several situations, such as vascular injury and epidermal wounds. We will determine, utilizing wild-type and Kel-/- mice, whether Kell, as an endothelin-converting enzyme, actively participates in an acidic microenvironment to promote neovascularization and cell proliferation which are integral to wound healing. We anticipate that findings from our proposed studies will shed important insights into the functions of two important but poorly understood red cell membrane proteins.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL075716-02
Application #
6847460
Study Section
Erythrocyte and Leukocyte Biology Study Section (ELB)
Program Officer
Barbosa, Luiz H
Project Start
2004-02-01
Project End
2008-01-31
Budget Start
2005-02-01
Budget End
2006-01-31
Support Year
2
Fiscal Year
2005
Total Cost
$302,895
Indirect Cost
Name
New York Blood Center
Department
Type
DUNS #
073271827
City
New York
State
NY
Country
United States
Zip Code
10065
Zhu, Xiang; Cho, Eun-Sook; Sha, Quan et al. (2014) Giant axon formation in mice lacking Kell, XK, or Kell and XK: animal models of McLeod neuroacanthocytosis syndrome. Am J Pathol 184:800-7
Rivera, Alicia; Kam, Siok Yuen; Ho, Mengfatt et al. (2013) Ablation of the Kell/Xk complex alters erythrocyte divalent cation homeostasis. Blood Cells Mol Dis 50:80-5
Velliquette, Randall W; Hue-Roye, Kim; Lomas-Francis, Christine et al. (2013) Molecular basis of two novel and related high-prevalence antigens in the Kell blood group system, KUCI and KANT, and their serologic and spatial association with K11 and KETI. Transfusion 53:2872-81
Dubielecka, Patrycja M; Hwynn, Nelson; Sengun, Cenk et al. (2011) Two McLeod patients with novel mutations in XK. J Neurol Sci 305:160-4
Zhu, Xiang; Rivera, Alicia; Golub, Mari S et al. (2009) Changes in red cell ion transport, reduced intratumoral neovascularization, and some mild motor function abnormalities accompany targeted disruption of the Mouse Kell gene (Kel). Am J Hematol 84:492-8
Araten, David J; Sanders, Katie J; Pu, Jeffrey et al. (2009) Spontaneously arising red cells with a McLeod-like phenotype in normal donors. Mutat Res 671:1-5
Salomao, Marcela; Zhang, Xihui; Yang, Yang et al. (2008) Protein 4.1R-dependent multiprotein complex: new insights into the structural organization of the red blood cell membrane. Proc Natl Acad Sci U S A 105:8026-31
Bansal, I; Jeon, H-R; Hui, S R et al. (2008) Transfusion support for a patient with McLeod phenotype without chronic granulomatous disease and with antibodies to Kx and Km. Vox Sang 94:216-20
Lee, Soohee; Sha, Quan; Wu, Xu et al. (2007) Expression profiles of mouse Kell, XK, and XPLAC mRNA. J Histochem Cytochem 55:365-74
Walker, Ruth H; Jung, Hans H; Tison, Francois et al. (2007) Phenotypic variation among brothers with the McLeod neuroacanthocytosis syndrome. Mov Disord 22:244-8

Showing the most recent 10 out of 16 publications